Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events.
Les I, Martínez M, Pérez-Francisco I, Cabero M, Teijeira L, Arrazubi V, Torrego N, Campillo-Calatayud A, Elejalde I, Kochan G, Escors D. Les I, et al. Among authors: arrazubi v. Cancers (Basel). 2023 Mar 6;15(5):1629. doi: 10.3390/cancers15051629. Cancers (Basel). 2023. PMID: 36900420 Free PMC article. Review.
Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective.
Teijeira L, Martínez M, Moreno A, de Elejoste I, Ibáñez-Beroiz B, Arrazubi V, Díaz de Corcuera I, Elejalde I, Campillo-Calatayud A, Les I. Teijeira L, et al. Among authors: arrazubi v. Cancers (Basel). 2023 Dec 28;16(1):151. doi: 10.3390/cancers16010151. Cancers (Basel). 2023. PMID: 38201577 Free PMC article.
Erratum to: Tailored Prevention of Functional Decline through a Multicomponent Exercise Program in Hospitalized Oncogeriatric Patients: Study Protocol for a Randomized Clinical Trial.
Martínez-Velilla N, Arrazubi V, Zambom-Ferraresi F, Morilla-Ruiz I, Sáez de Asteasu ML, Ramírez-Vélez R, De la Casa-Marín A, Ollo-Martínez I, Gorospe-García I, Gurruchaga-Sotés I, Galbete A, Cedeño-Veloz BA, Martín-Nevado L, Izquierdo M, Vera R. Martínez-Velilla N, et al. Among authors: arrazubi v. J Nutr Health Aging. 2023 Dec;27(12):1287. doi: 10.1007/s12603-023-2033-7. J Nutr Health Aging. 2023. PMID: 38242605 Free article. No abstract available.
Tailored Prevention of Functional Decline through a Multicomponent Exercise Program in Hospitalized Oncogeriatric Patients: Study Protocol for a Randomized Clinical Trial.
Martínez-Velilla N, Arrazubi V, Zambom-Ferraresi F, Morilla-Ruiz I, Sáez de Asteasuu ML, Ramírez-Vélez R, Zambom-Ferraresi F, De la Casa-Marín A, Ollo-Martínez I, Gorospe-García I, Gurruchaga-Sotés I, Galbete A, Cedeño-Veloz BA, Martín-Nevado L, Izquierdo M, Vera R. Martínez-Velilla N, et al. Among authors: arrazubi v. J Nutr Health Aging. 2023;27(10):911-918. doi: 10.1007/s12603-023-1977-y. J Nutr Health Aging. 2023. PMID: 37960915 Free article.
Is there a preferred platinum and fluoropyrimidine regimen for advanced HER2-negative esophagogastric adenocarcinoma? Insights from 1293 patients in AGAMENON-SEOM registry.
Arias-Martinez A, Martínez de Castro E, Gallego J, Arrazubi V, Custodio A, Fernández Montes A, Diez M, Hernandez R, Limón ML, Cano JM, Vidal-Tocino R, Macias I, Visa L, Martin Richard M, Sauri T, Hierro C, Gil M, Cerda P, Martínez Moreno E, Martínez Lago N, Mérida-García AJ, Gómez González L, García Navalón FJ, Ruiz Martín M, Marín G, López-López F, Ruperez Blanco AB, Fernández AF, Jimenez-Fonseca P, Carmona-Bayonas A, Alvarez-Manceñido F. Arias-Martinez A, et al. Among authors: arrazubi v. Clin Transl Oncol. 2024 Feb 15. doi: 10.1007/s12094-024-03388-6. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38361134
State of the scientific evidence and recommendations for the management of older patients with gastric cancer.
Paredero-Pérez I, Jimenez-Fonseca P, Cano JM, Arrazubi V, Carmona-Bayonas A, Covela-Rúa M, Fernández-Montes A, Martín-Richard M, Gironés-Sarrió R. Paredero-Pérez I, et al. Among authors: arrazubi v. J Geriatr Oncol. 2024 Apr;15(3):101657. doi: 10.1016/j.jgo.2023.101657. Epub 2023 Nov 11. J Geriatr Oncol. 2024. PMID: 37957106 Free article. Review.
Phase 4 Multinational Multicenter Retrospective and Prospective Real-World Study of Nivolumab in Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck.
Gogate A, Bennett B, Poonja Z, Stewart G, Medina Colmenero A, Szturz P, Carrington C, Castro C, Gemmen E, Lau A, Carral Maseda A, Winquist E, Arrazubi V, Hao D, Cook A, Martinez Galan J, Ugidos L, Fernández Garay D, Gutierrez Abad D, Metcalf R. Gogate A, et al. Among authors: arrazubi v. Cancers (Basel). 2023 Jul 9;15(14):3552. doi: 10.3390/cancers15143552. Cancers (Basel). 2023. PMID: 37509217 Free PMC article.
State of the Art: ctDNA in Upper Gastrointestinal Malignancies.
Labiano I, Huerta AE, Arrazubi V, Hernandez-Garcia I, Mata E, Gomez D, Arasanz H, Vera R, Alsina M. Labiano I, et al. Among authors: arrazubi v. Cancers (Basel). 2023 Feb 21;15(5):1379. doi: 10.3390/cancers15051379. Cancers (Basel). 2023. PMID: 36900172 Free PMC article. Review.
The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Jimenez-Fonseca P, Foy V, Raby S, Carmona-Bayonas A, Macía-Rivas L, Arrazubi V, Cacho Lavin D, Hernandez San Gil R, Custodio A, Cano JM, Fernández Montes A, Mirallas O, Macias Declara I, Vidal Tocino R, Visa L, Limón ML, Pimentel P, Martínez Lago N, Sauri T, Martín Richard M, Mangas M, Gil Raga M, Calvo A, Reguera P, Granja M, Martín Carnicero A, Hernández Pérez C, Cerdá P, Gomez Gonzalez L, Garcia Navalon F, Pacheco Barcia V, Gutierrez Abad D, Ruiz Martín M, Weaver J, Mansoor W, Gallego J. Jimenez-Fonseca P, et al. Among authors: arrazubi v. Ther Adv Med Oncol. 2023 Mar 4;15:17588359231157641. doi: 10.1177/17588359231157641. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36895850 Free PMC article.
45 results